SCHEMBL7835005

SCHEMBL7835005

COc1cc(Nc2ccccc2C(C)=O)cc(OC)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 8/20 0.62
AKR1C2 P52895 8/20 0.62
SMN1; SMN2 Q16637 3/20 0.53
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
HTT P42858 1/20 0.53
MAPT P10636 1/20 0.51
ALOX15 P16050 1/20 0.51
CDC25B P30305 1/20 0.50
KDM4E B2RXH2 1/20 0.50
TSHR P16473 1/20 0.50
HSD17B10 Q99714 1/20 0.50
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
MAPK1 P28482 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7844457 0.88 AKR1C3 (0.66) AKR1C3AKR1C2SMN1; SMN2NPC1RAB9A
SCHEMBL10935935 0.86 MEN1 (0.60) AKR1C3AKR1C2NPC1RAB9AHTT
SCHEMBL30567368 0.79 AKR1C3 (0.65) AKR1C3AKR1C2SMN1; SMN2RAB9AMAPT
SCHEMBL10935377 0.79 AKR1C3 (0.65) AKR1C3AKR1C2SMN1; SMN2RAB9AMAPT
SCHEMBL848485 0.78 MAPT (0.68) AKR1C3AKR1C2MAPTALOX15MEN1
SCHEMBL30567367 0.78 MAPT (0.68) AKR1C3AKR1C2MAPTALOX15MEN1
SCHEMBL10937347 0.78 GAA (0.57) AKR1C3AKR1C2NPC1RAB9ACDC25B
SCHEMBL25449209 0.77 AKR1C3 (0.66) AKR1C3AKR1C2MAPTALOX15CDC25B
SCHEMBL848495 0.77 AKR1C3 (0.67) AKR1C3AKR1C2SMN1; SMN2MAPTALOX15
SCHEMBL846875 0.77 AKR1C3 (0.81) AKR1C3AKR1C2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0646112-A4 TERTIARY AND SECONDARY AMINES AS ALPHA-2 ANTAGONISTS AND SEROTONIN UPTAKE INHIBITORS. ABBOTT LAB (US) 1997-04-02 EP claimed
EP-0646112-A1 TERTIARY AND SECONDARY AMINES AS ALPHA-2 ANTAGONISTS AND SEROTONIN UPTAKE INHIBITORS ABBOTT LABORATORIES (US) 1995-04-05 EP claimed
EP-0783505-B1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE NOVARTIS AG (CH) 2001-03-07 EP disclosed
US-5869485-A Pyrrolo 2,3-d!pyrimidines and their use NOVARTIS FINANCE CORP. (US) 1999-02-09 US disclosed
EP-0783505-A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE Novartis AG (CH) 1997-07-16 EP disclosed
WO-1996010028-A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE NOVARTIS AG (CH) 1996-04-04 WO disclosed